Innate Immune Response of Human Alveolar Type II Cells Infected With Severe Acute Respiratory Syndrome-Coronavirus

Am J Respir Cell Mol Biol. 2013 Jun;48(6):742-8. doi: 10.1165/rcmb.2012-0339OC.

Abstract

Severe acute respiratory syndrome (SARS)-coronavirus (CoV) produces a devastating primary viral pneumonia with diffuse alveolar damage and a marked increase in circulating cytokines. One of the major cell types to be infected is the alveolar type II cell. However, the innate immune response of primary human alveolar epithelial cells infected with SARS-CoV has not been defined. Our objectives included developing a culture system permissive for SARS-CoV infection in primary human type II cells and defining their innate immune response. Culturing primary human alveolar type II cells at an air-liquid interface (A/L) improved their differentiation and greatly increased their susceptibility to infection, allowing us to define their primary interferon and chemokine responses. Viral antigens were detected in the cytoplasm of infected type II cells, electron micrographs demonstrated secretory vesicles filled with virions, virus RNA concentrations increased with time, and infectious virions were released by exocytosis from the apical surface of polarized type II cells. A marked increase was evident in the mRNA concentrations of interferon-β and interferon-λ (IL-29) and in a large number of proinflammatory cytokines and chemokines. A surprising finding involved the variability of expression of angiotensin-converting enzyme-2, the SARS-CoV receptor, in type II cells from different donors. In conclusion, the cultivation of alveolar type II cells at an air-liquid interface provides primary cultures in which to study the pulmonary innate immune responses to infection with SARS-CoV, and to explore possible therapeutic approaches to modulating these innate immune responses.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Viral / immunology
  • Antigens, Viral / metabolism
  • Cell Differentiation
  • Cytoplasm / immunology
  • Cytoplasm / ultrastructure
  • Cytoplasm / virology
  • Epithelial Cells / immunology*
  • Epithelial Cells / virology
  • Humans
  • Immunity, Innate*
  • Interferon-beta / immunology
  • Interferon-beta / metabolism
  • Interferons
  • Interleukins / immunology
  • Interleukins / metabolism
  • Peptidyl-Dipeptidase A / immunology
  • Peptidyl-Dipeptidase A / metabolism
  • Primary Cell Culture
  • Pulmonary Alveoli / cytology
  • Pulmonary Alveoli / immunology
  • Pulmonary Alveoli / virology
  • RNA, Messenger / metabolism
  • Receptors, Virus / metabolism
  • Respiratory Mucosa / cytology
  • Respiratory Mucosa / immunology
  • Respiratory Mucosa / virology
  • SARS Virus / immunology*
  • Severe Acute Respiratory Syndrome / immunology*
  • Time Factors
  • Virus Release

Substances

  • Antigens, Viral
  • IFNL1 protein, human
  • Interleukins
  • RNA, Messenger
  • Receptors, Virus
  • Interferon-beta
  • Interferons
  • Peptidyl-Dipeptidase A
  • angiotensin converting enzyme 2